Acurx Pharmaceuticals Statistics
Total Valuation
ACXP has a market cap or net worth of $34.18 million. The enterprise value is $25.26 million.
Market Cap | 34.18M |
Enterprise Value | 25.26M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, before market open.
Earnings Date | Aug 12, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
ACXP has 15.82 million shares outstanding. The number of shares has increased by 32.93% in one year.
Shares Outstanding | 15.82M |
Shares Change (YoY) | +32.93% |
Shares Change (QoQ) | +11.79% |
Owned by Insiders (%) | 15.18% |
Owned by Institutions (%) | 12.47% |
Float | 13.44M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.70 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.93, with zero debt.
Current Ratio | 2.93 |
Quick Ratio | n/a |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -308.50% and return on invested capital (ROIC) is -267.61%.
Return on Equity (ROE) | -308.50% |
Return on Assets (ROA) | -193.30% |
Return on Capital (ROIC) | -267.61% |
Revenue Per Employee | n/a |
Profits Per Employee | -$4.01M |
Employee Count | 4 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.29% in the last 52 weeks. The beta is -1.70, so ACXP's price volatility has been lower than the market average.
Beta (5Y) | -1.70 |
52-Week Price Change | -15.29% |
50-Day Moving Average | 2.28 |
200-Day Moving Average | 2.98 |
Relative Strength Index (RSI) | 41.84 |
Average Volume (20 Days) | 30,414 |
Short Selling Information
The latest short interest is 661,209, so 4.18% of the outstanding shares have been sold short.
Short Interest | 661,209 |
Short Previous Month | 688,377 |
Short % of Shares Out | 4.18% |
Short % of Float | 4.92% |
Short Ratio (days to cover) | 10.90 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -16.05M |
Pretax Income | -16.05M |
Net Income | -16.05M |
EBITDA | -16.05M |
EBIT | -16.05M |
Earnings Per Share (EPS) | -$1.18 |
Balance Sheet
The company has $8.92 million in cash and no debt, giving a net cash position of $8.92 million or $0.56 per share.
Cash & Cash Equivalents | 8.92M |
Total Debt | n/a |
Net Cash | 8.92M |
Net Cash Per Share | $0.56 |
Equity (Book Value) | 6.00M |
Book Value Per Share | 0.38 |
Working Capital | 6.00M |
Cash Flow
Operating Cash Flow | -10.93M |
Capital Expenditures | n/a |
Free Cash Flow | -10.93M |
FCF Per Share | -$0.71 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
ACXP does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -32.93% |
Shareholder Yield | -32.93% |
Earnings Yield | -46.97% |
FCF Yield | -31.98% |
Analyst Forecast
The average price target for ACXP is $12.00, which is 455.56% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $12.00 |
Price Target Difference | 455.56% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | 29.52% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |